Corrected Visual Acuity as the Foundation of Effective Myopia Control: A 1-Year Real-World Cohort Study in 9-Year-Old Children

This one-year real-world cohort study of 9-year-old children demonstrates that achieving normal corrected visual acuity with single-vision spectacles is essential for effectively slowing myopia progression, as under-correction or lack of correction leads to significantly faster axial elongation.

The Gist

🧐 The Big Question: Is "Good Enough" Good Enough?

Imagine you are trying to drive a car. If your windshield is slightly foggy or scratched, you can still see the road, right? You might get to your destination, but you'll be driving slower, more cautiously, and maybe even a bit more dangerously than if the glass were crystal clear.

For a long time, eye doctors and parents have thought: "As long as the child has glasses and can see the board at school, we are doing our job."

This study asked a bold question: Is "seeing okay" actually the same as "seeing perfectly"? Or, does that slight blur act like a hidden accelerator for nearsightedness (myopia)?

🔬 The Experiment: A Real-World Race

The researchers followed 1,525 nine-year-old children in Chengdu, China, for one year. They didn't put them in a lab; they watched them in their real lives (schools, homes).

They sorted the kids into three teams based on how well their glasses worked:

1. The "Crystal Clear" Team (POCG): These kids wore glasses that gave them perfect vision (20/20 or better).
2. The "Slightly Foggy" Team (UCG): These kids wore glasses, but their vision was still a bit blurry. They were "under-corrected."
3. The "No Glasses" Team (USMG): These kids were nearsighted but didn't wear glasses at all.

The Goal: To see which team's eyeballs grew the longest (axial length) over the year. In eye science, longer eyeballs = worse nearsightedness. Think of the eyeball like a balloon; as it stretches, your vision gets blurrier.

🏁 The Results: The Power of Clarity

The study used a clever statistical trick (like a referee pairing up runners with similar starting speeds) to make sure the comparison was fair. Here is what happened:

• The "Crystal Clear" Team: Their eyeballs grew the slowest. They were the winners.
• The "Slightly Foggy" Team: Their eyeballs grew much faster than the Crystal Clear team. In fact, they grew almost as fast as the kids with no glasses at all.
• The "No Glasses" Team: Their eyeballs grew the fastest (or tied with the "Foggy" team).

The Analogy:
Imagine the eye is a garden hose.

• Perfect Vision is like a hose with a steady, clear stream of water. The garden (the eye) stays healthy and doesn't stretch out.
• Blurry Vision (even with glasses) is like a hose with a kink in it. The water (light) is struggling to get through. The eye tries to "stretch" to find the focus, and that stretching makes the nearsightedness get worse, faster.

💡 The Surprising Twist

The most important finding wasn't just that perfect vision is good. It was that having glasses that don't work perfectly is almost as bad as having no glasses at all.

The "Slightly Foggy" team thought they were safe because they had glasses. But because their vision wasn't sharp, their eyes kept stretching. The study found that the tiny benefit of wearing "okay" glasses was negligible. It's like wearing a helmet that is slightly too big; it's better than nothing, but it doesn't actually protect your head very well.

🛠️ What Should We Do? (The Takeaway)

The authors suggest we need to change how we think about eye care for kids:

1. Stop settling for "Good Enough": If a child gets glasses, we can't just say, "Great, they can see the board." We need to check: Is their vision actually sharp?
2. The "Check-Up" Loop: Just getting the glasses isn't the finish line. We need to check back in 1–3 months to make sure the prescription is still perfect. Kids' eyes change fast!
3. Clear Vision is the Goal: The ultimate goal of myopia control isn't just "giving them glasses." It's ensuring they have crystal clear vision every single day.

🎯 In a Nutshell

Think of myopia control like training for a marathon.

• No Glasses: You are running in heavy boots. You get tired and slow down fast.
• Blurry Glasses: You are running in sneakers that are the wrong size. You can run, but you are tripping and your feet hurt. You still get tired fast.
• Perfect Glasses: You are running in custom-fitted, lightweight shoes. You can run efficiently and keep your pace.

The lesson: Don't just give kids glasses. Make sure those glasses give them perfect vision, or the nearsightedness will keep speeding up.

Technical Summary

1. Problem Statement

Myopia progression in children is a critical global public health issue, significantly increasing the risk of high myopia and vision-threatening complications. While single-vision spectacles are the most common first-line intervention, their efficacy in slowing myopia progression is often inconsistent.

• The Gap: Previous studies have not sufficiently isolated Corrected Distance Visual Acuity (CDVA) as an independent variable. A significant portion of spectacle-wearing children suffer from undercorrection (suboptimal CDVA), leading to persistent retinal defocus.
• The Hypothesis: The study posits that the quality of visual rehabilitation (achieving normal CDVA) is the cornerstone of effective myopia control, rather than merely the provision of spectacles.
• Ethical Constraint: Randomized Controlled Trials (RCTs) assigning children to undercorrected conditions are ethically unfeasible. Therefore, high-quality observational studies using causal inference methods are required to address this clinical question.

2. Methodology

Study Design & Population:

• Type: Retrospective, school-based real-world cohort study with 1-year longitudinal follow-up.
• Location: Chengdu, Sichuan Province, China (2019–2024).
• Participants: 1,525 children aged 9 years with myopia (Spherical Equivalent [SE] between –0.50 D and –6.00 D).
• Exclusion: Children using adjunctive myopia control interventions (e.g., atropine, orthokeratology, specialized lenses), those with organic ocular disease, or anisometropia >1.50 D.

Group Classification:
Participants were categorized into three mutually exclusive groups based on 1-year longitudinal data:

1. Untreated Screened Myopia Group (USMG): Myopic children without any optical correction ($n=1,125$).
2. Protocol-Defined Optimal Correction Group (POCG): Spectacle wearers achieving normal CDVA (<0.0 logMAR) at all visits ($n=134$).
3. Under-Corrected Group (UCG): Spectacle wearers with suboptimal CDVA (≥0.0 logMAR) at all visits ($n=266$).

Data Collection & Analysis:

• Examinations: Conducted every 6 months by certified optometrists. Measurements included UCVA, CDVA, SE, Axial Length (AL), Anterior Chamber Depth (ACD), Lens Thickness (LT), and Corneal Curvature (K1, K2) using non-cycloplegic autorefraction and optical biometry.
• Statistical Approach:
  • Propensity Score Matching (PSM): Used to minimize confounding bias. A 1:1 nearest-neighbor matching (caliper = 0.2) was performed, stratified by sex and baseline SE.
  • Covariates: Age, sex, baseline SE, AL, K1, K2, ACD, and LT.
  • Outcome Measures: Annualized axial length change ($\Delta$AL, mm/year) over the full year, and semi-annual intervals ($\Delta$AL1, $\Delta$AL2).
  • Software: Python 3.9.6 (Statsmodels).

3. Key Contributions

• Isolation of CDVA: This study is among the first to treat "persistently suboptimal CDVA" as a distinct exposure variable, separating the effects of wearing glasses from wearing the correct glasses.
• Real-World Evidence: By utilizing a large cohort from ordinary schools rather than specialized clinics, the study reflects the true prevalence of undercorrection and untreated myopia in the general population (73.77% untreated, 14.81% undercorrected in the raw data).
• Causal Inference in Observational Data: The rigorous application of PSM allows for a robust comparison of axial elongation rates between groups that would otherwise be confounded by baseline differences in refractive error and biometry.

4. Key Results

After Propensity Score Matching, the study compared axial elongation rates across the groups:

A. Optimal Correction (POCG) vs. Under-Correction (UCG)

• Result: The POCG demonstrated significantly slower axial elongation than the UCG.
• Data:
  • POCG: $0.23 \pm 0.14$ mm/year.
  • UCG: $0.35 \pm 0.14$ mm/year.
  • Difference: $0.13$ mm/year reduction ($P < 0.001$).
  • Relative Reduction: 34.3% slower progression in the optimally corrected group.
• Consistency: This benefit was sustained across both semi-annual intervals ($\Delta$AL1 and $\Delta$AL2).

B. Under-Correction (UCG) vs. Untreated (USMG)

• Result: The benefit of undercorrection over no correction was marginal and clinically insignificant.
• Data:
  • UCG: $0.34 \pm 0.13$ mm/year.
  • USMG: $0.37 \pm 0.16$ mm/year.
  • Difference: $-0.03$ mm/year ($P = 0.04$).
• Nuance: While statistically significant in the annual pooled analysis, this marginal benefit disappeared in semi-annual analyses ($P > 0.30$), indicating no consistent protective effect of undercorrection.

C. Optimal Correction (POCG) vs. Untreated (USMG)

• Result: Optimal correction provided the most significant protection.
• Data: POCG showed a $0.15$ mm/year reduction compared to USMG ($P < 0.001$), representing a 40.5% relative reduction in axial elongation.

5. Significance and Implications

• Clinical Practice: Simply prescribing spectacles is insufficient for myopia control. The primary goal must be achieving and maintaining normal corrected visual acuity (CDVA). Undercorrection offers negligible clinical benefit over no treatment.
• Mechanism: The study supports the "blur–compensation–accelerated growth" hypothesis. Suboptimal correction leads to chronic retinal defocus and excessive accommodation, triggering hyperopic defocus signals that drive axial elongation. Optimal correction eliminates this defocus.
• Public Health Policy: The authors propose a new framework for myopia management:
  1. Dynamic Monitoring: Shift from annual static screenings to high-frequency (quarterly/monthly) monitoring.
  2. Closed-Loop System: Implement a "prescription–verification–follow-up" cycle, mandating CDVA reassessment 1–3 months post-prescription.
  3. New Metrics: Move public health indicators from "spectacle coverage rates" to "CDVA achievement rates" and "axial elongation rates."
• Limitations: The study used non-cycloplegic refraction (standard in school screenings) and is observational, meaning it cannot definitively prove causality, though it strongly suggests a critical association.

Conclusion:
Achieving normal corrected visual acuity is the foundational requirement for effective myopia control in children wearing single-vision spectacles. The study provides strong evidence that correcting vision to a normal standard significantly slows axial elongation, whereas undercorrection fails to provide meaningful protection.